Parexel unveils platform designed to make clinical drug trials more efficient

Parexel International Corp. announced Monday the launch of a platform that is designed to simplify the clinical trial process for experimental drugs.

Headquartered in Waltham, Parexel provides services to pharmaceutical companies looking to develop and commercialize new drugs.


In a press release, Parexel said it is calling its new offering the Parexel MyTrials platform.

‘‘In recent years there has been an increase in the number of applications for managing the clinical trials process, but these independent systems are not necessarily compatible with each other, for example, forcing users to enter the same data multiple times in different applications,” Dr. Mark A. Goldberg, Parexel’s chief operating officer, said in a statement. “This disrupts optimal workflow and processes, resulting in an unintended loss of productivity. Sponsors and investigator site users are looking for a unified solution to plan, design, and conduct their clinical trial programs.  With the availability of Parexel MyTrials, users will have a single place to access a comprehensive suite of applications, tools, metrics, and reports through full data integration and application convergence.”

Parexel made its announcement as many life sciences companies converge on Boston, which is playing host this week to an industry convention known as BIO.

Chris Reidy can be reached at
Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of